- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Progesterone Receptor-negative
Total 3805 results
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.Active, not recruitingTriple Negative Breast CancerUnited States, Canada
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Dana-Farber Cancer InstituteTranslational Breast Cancer Research Consortium; Myriad Genetics, Inc.CompletedTriple Negative Breast CancerUnited States
-
Providence Health & ServicesMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States
-
University of ChicagoActive, not recruiting
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruiting
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
MedSIRHoffmann-La RocheCompletedTriple Negative Breast CancerSpain, Portugal
-
Massachusetts General HospitalAstraZeneca; OncoPep, Inc.Active, not recruitingBreast CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul CancroCompletedTriple Negative Breast CancerItaly
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States, Australia
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Institut Claudius RegaudCompletedTriple Negative Breast CancerFrance
-
George Washington UniversityWithdrawnTriple Negative Breast CancerUnited States
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
Universidad Nacional de ColombiaFundación Salud de los AndesCompletedBreast Cancer | Triple Negative Breast CancerColombia
-
Gilead SciencesCompletedBreast CancerUnited States, Canada, Spain, France, Belgium, United Kingdom, Germany
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; ExelixisCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Fudan UniversityUnknown
-
The University of Texas Health Science Center at...Completed
-
Icahn School of Medicine at Mount SinaiChampions OncologyCompletedTriple Negative Breast CancerUnited States
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
The Christie NHS Foundation TrustUniversity of ManchesterWithdrawn
-
Fudan UniversityUnknownTriple Negative Breast CancerChina
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Neoplasms | Breast Diseases
-
Tianjin Medical University Cancer Institute and...UnknownTriple Negative Breast CancerChina
-
Columbia UniversityAstellas Pharma Inc; Susan G. Komen Breast Cancer FoundationCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
SCRI Development Innovations, LLCPfizerCompletedBreast CancerUnited States
-
Washington University School of MedicineTerminatedBreast CancerUnited States
-
University of ChicagoWithdrawn
-
Fudan UniversityUnknown
-
Cancer Institute and Hospital, Chinese Academy...UnknownTriple Negative Breast CancerChina
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Imugene LimitedActive, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedHealthy | Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Chang Gung Memorial HospitalCompletedParonychia | Epidermal Growth Factor Receptor InhibitorTaiwan
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States